Clinically effective child change in family-based behavioral treatment for pediatric obesity: An individual

Leonard H Epstein1, Nicholas V Neuwald1, Rocco A Paluch1

  • 1Department of Pediatrics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo.

Insights

Family-based behavioral treatment (FBT) demonstrates significant clinical effectiveness for pediatric obesity, with long-term benefits in body mass index z-score (zBMI) and obesity reversal. Younger children show greater improvements, highlighting FBT

Area of Science:

  • Pediatric Endocrinology
  • Behavioral Health
  • Obesity Medicine

Background:

  • Family-based behavioral treatment (FBT) is an established intervention for childhood overweight and obesity.
  • While statistically significant, the clinical significance of FBT, particularly in relation to cardiometabolic disease prevention, requires further evaluation.
  • Defining clinically meaningful changes in body mass index z-score (zBMI) is crucial for assessing treatment impact.

Purpose of the Study:

  • To evaluate the clinical effectiveness of FBT using a mega-analysis of randomized controlled trials.
  • To determine the percentage of children achieving a clinically significant zBMI reduction (-0.25) and obesity reversal at multiple long-term follow-up points.
  • To investigate age and sex as predictors of treatment response in pediatric obesity.

Main Methods:

  • A mega-analysis of 16 randomized controlled studies involving 1,098 children (aged 6-12) with overweight/obesity and their parents.
  • Individual participant data were analyzed to assess zBMI change and obesity status at 6, 12, 24, 60, and 120 months.
  • Statistical analyses examined the proportion meeting the -0.25 zBMI criterion and obesity reversal, alongside predictor variables like age and sex.

Main Results:

  • A substantial proportion of children met the -0.25 zBMI criteria at all follow-ups: 70% (6 months) to 68% (120 months).
  • Obesity reversal rates increased significantly over time, from 29% at 6 months to 48% at 120 months.
  • Younger age was identified as a reliable predictor of greater zBMI change up to 24 months.

Conclusions:

  • FBT demonstrates sustained clinical effectiveness in pediatric obesity treatment, with outcomes improving or remaining stable long-term.
  • The findings support the clinical utility of FBT, complementing traditional statistical significance reporting.
  • This study provides valuable data on the long-term clinical effectiveness of FBT for childhood obesity.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Behavior Modification01:21

Behavior Modification

Behavioral approaches have often been criticized for ignoring mental processes and focusing solely on observable behavior. However, these approaches provide an optimistic perspective for individuals seeking to change their behaviors. Rather than concentrating on intrinsic personality traits, behavioral approaches suggest that even longstanding habits can be modified by changing the reward contingencies that maintain them.
A real-world application of operant conditioning principles is applied...
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Family Therapy01:30

Family Therapy

Family therapy conceptualizes psychological challenges as arising from dysfunctional interactions within the family unit, rather than as isolated issues within individuals. This approach seeks to address and transform the patterns of communication, roles, and relationships within families to promote healthier dynamics and emotional well-being for all members.
Strategic Family Therapy
Strategic family therapy emphasizes resolving communication barriers and improving problem-solving abilities...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...